left arrow Nov 17, 2026

AZB & Partners advised a consortium of lenders, including Investec India, Bain Capital, Tata Capital, Trust Capital and Aditya Birla Capital, on approximately INR 2,000 crore of structured private credit for Anupam Rasayan India Limited’s acquisition of a 48.2% stake in Bliss GVS Pharma Limited.

AZB & Partners advised a consortium of lenders, including Investec India, Bain Capital, Tata Capital, Trust Capital and Aditya Birla Capital, on approximately INR 2,000 crore of structured private credit for Anupam Rasayan India Limited’s acquisition of a 48.2% stake in Bliss GVS Pharma Limited.

The deal team comprised our Senior Partner Anand Shah and Partner Shivanand Nayak; along with Senior Associate Prasham Shah and Associates Devavrat Nimbalkar and Vedant Heda; with support from Articled Clearks Isha Kulkarni and Palomi Visaria. The regulatory and due diligence team comprised our Partner Abhilash Chandran; along with Senior Associate Aayush Raman; Associate Yashvi Bhagat; and Articled Cleark Mehar Kalra.

AUTHORS & CONTRIBUTORS

TAGS

SHARE

DISCLAIMER

These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.